Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
58.55(c) 57.69(c) 59.19(c) 60.79(c) 61.3(c) Last
6 944 503 7 603 903 7 136 963 6 976 010 10 326 593 Volume
-0.34% -1.47% +2.60% +2.70% +0.84% Change
More quotes
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
01/27Earnings Release
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 15 676 M
EBIT 2014 3 381 M
Net income 2014 2 439 M
Finance 2014 626 M
Yield 2014 2,35%
Sales 2015 15 724 M
EBIT 2015 3 240 M
Net income 2015 2 466 M
Finance 2015 1 568 M
Yield 2015 2,40%
PER 2014 43,27
PER 2015 37,82
EV / Sales 2014 6,45x
EV / Sales 2015 6,37x
Capitalization 101 683 M
More Financials
Latest news on BRISTOL-MYERS SQUIBB CO
3d ago BRISTOL MYERS SQUIBB : Reports Outline Hepatitis C Virus and Genetics Study Resu..
3d ago BRISTOL MYERS SQUIBB : Studies from Bristol-Myers Squibb Update Current Data on ..
3d ago Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immun..
4d ago BRISTOL MYERS SQUIBB : to Announce Results for Fourth Quarter, Full Year 2014 on..
4d ago Ono Pharma, Bristol-Myers & Kyowa Hakko Kirin enter pact to condutct phase 1 ..
4d ago BRISTOL MYERS SQUIBB : Assigned Patent
5d agoDJMetLife, TRW Sign $440 Million Pension Buyout Agreement
12/12DJDanone Committed to All Business Units -- 2nd Update
More news
Sector news
4h ago MERCK : buys new-cancer-drug firm
12h ago Fear factor fades as global M&A hits seven-year high
1d ago AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF